Mapk10 (JNK3) was shown to be silenced or downregulated in a majority of the HCC cell lines or primary HCC tumor samples examined, while the demethylating reagent could restore its expression in silenced HCC cells. The gene discussed is MAPK10; the disease is hepatocellular carcinoma.